# US 2009/0264499 A1 · Cathepsin C Inhibitors

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2009/0264499 A1
- Document ID: US20090264499A1
- Status: Published application
- Kind: A1
- Application number: 12/424,882
- Filed: 2009-04-16
- Published: 2009-10-22
- Earliest claimed: 2008-04-18
- Inventors: Jianghe DENG; Dramane Ibrahim Laine; Brent W. McCleland; Michael R. Palovich; Emilie Veronique Petitjean
- Web page: https://patentgrep.com/patent/US20090264499A1

## CPC

- C07D 207/14: Nitrogen atoms not forming part of a nitro radical
- A61P 11/00: Drugs for disorders of the respiratory system
- A61P 11/08: Bronchodilators
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- C07D 403/12: linked by a chain containing hetero atoms as chain links
- C07D 405/12: linked by a chain containing hetero atoms as chain links
- C07D 413/12: linked by a chain containing hetero atoms as chain links
- C07D 417/12: linked by a chain containing hetero atoms as chain links
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A compound of formula (IA) or (IB) and their use in treating inflammatory diseases such as COPD.

## Claims

### Claim 1

A compound of formula (IA) or (IB)
and a salt thereof wherein
n is 1-5,
each R1 is independently halo; OR2; C1-C10alkyl unsubstituted, or substituted by halo or a unsubstituted or substituted heteraromatic ring containing 1-3 heteroatoms selected from the group consisting of N, O or S;; CN; C(O)NR3R4; NO2; NHC(O)NR5R6; NR7R8; a heteraromatic ring containing 1-3 heteroatoms selected from the group consisting of N, O or S; aryl, unsubstituted or substituted by halo or C1-C6 alkyl; C3-C6cycloalkyl; C4-C6cycloalkenyl; C1-C10alkenyl; C1-C10alkynyl; or C(O)OR2;
R2 is H, C1-C6 alkyl, haloC1-C6 alkyl, C(O)R9;
R3 is H; C1-C6 alkyl; C3-C6cycloalkyl; or C3-C6heterocycloalkyl containing N, O or S and where when the ring heteroatom is N it is optionally substituted by CN;
R4 is H, or C1-C6 alkyl;
R5 and R6 are independently H; C1-C6alkyl; aryl unsubstituted or substituted by halo, C1-C4alkoxy, C1-C4alkyl, or OR2; C1-C10 alkyl unsubstituted or substituted by halo or C1-C4alkoxy; C3-C6cycloalkyl; C3-C6cycloalkylalkyl; C1-C10alkenyl; C1-C10alkynyl; C3-C6heteroycloalkyl; C3-C6heteroycloalkyl C1-C6alkyl; heteroarylC1-C6alkyl or heteroaryl wherein the heteroaryl ring is unsubstituted or substituted by halo, C1-C6 alkyl or halo-substituted-C1-C6 alkyl; or arylC1-C6alkyl wherein the aryl group is unsubstituted or substituted by halo, OR2, or C(O);
R7 and R8 are independently H; C1-C10alkyl; arylC1-C6alkyl wherein the aryl group is unsubstituted or substituted by R9, halo, or C1-C6alkyl; C1-C10alkyl substituted by C3-C6cycloalkyl, one or more OH groups, halo; heteroarylC1-C6alkyl; or heteroaryl; or
R9 is OH, C1-C6 alkyoxy or NR2′R3′, wherein R2′ or R3 are independently H or C1-C6alkyl.

### Claim 2 (depends on 1)

A compound of formula (IA) or (IB) according to claim 1 or a salt thereof wherein
n is 1-4 and
R1 is independently halo; OR2; C1-C10alkyl unsubstituted or substituted by halo or a unsubstituted or substituted heteraromatic ring containing 1-3 heteroatoms selected from the group consisting of N, O or S; CN; C(O)NR3R4; NO2; NHC(O)NR5R6; NR7R8; a heteraromatic ring containing 1-3 heteroatoms selected from the group consisting of N, O or S; aryl, unsubstituted or substituted by halo or C1-C6 alkyl; C3-C6cycloalkyl; C1-C10alkenyl; or C(O)OR2.

### Claim 3 (depends on 1)

A compound of formula (IA) or (IB) according to claim 1 or a salt thereof wherein n is 1, or 2 or 4.

### Claim 4 (depends on 1)

A compound of formula (IA) according to claim 1 or a salt thereof wherein n is 1, or 2 or 4; and
R1 is cyano, (ethylamino)carbonyl-mino, (phenylamino)carbonyl-amino, 5-methyl-1,3,4-oxadiazol-2-yl, fluorophenyl, (3-hydroxyphenyl)methyl]amino, (2,3-dihydroxypropyl)amino, (cyclopropylmethyl)amino, pentylamino, (3-methylbutyl)amino, (2-methylbutyl)amino, (3,3-dimethylbutyl)amino, (3-furanylmethyl)amino, (2-methylpentyl)amino, (3-methylpentyl)amino, nonylamino, (1,3-thiazol-2-ylmethyl)amino, (phenylmethyl)amino, (3-fluorophenyl)methylamino, (4-hydroxyphenyl)methyl-amino, 2-furanylamino, (2-chloroethyl)amino, (2,3-dihydroxypropyl)amino, butylamino, pentylamino, bis(3-methylbutyl)amino, bis(3,3-dimethylbutyl)amino, (2-methylpentyl)amino, (1,3-thiazol-2-ylmethyl)amino, (3-hydroxyphenyl)methyl, 1,2-dideoxy-D-erythro-pentitol, —NC(O)CH2-phenyl(methoxy), NC(O)phenyl(methoxy), 4-pentenamide, pentanamide, 3-methylbutanamide, 2,2-dimethylpropanamide, cyclopentanecarboxamide, 2H-pyran-4-carboxamide, 2-methylpentanamide, hexanamide, propanamide, 2-ethylbutanamide, 3-methylpentanamide, 5-methyl-2-(trifluoromethyl)-3-furancarboxamide, heptanamide, 2,2,3,3-tetrafluoropropanamide, 3-(methyloxy)propanamide, cyclobutanecarboxamide, 2-furancarboxamide, 1-methyl-1H-pyrazole-4-carboxamide, 2-methylbutanamide, 2,2-dimethylpropanamide, (2,2,2-trifluoroethyl)oxy, or C(O)OMe.

### Claim 5 (depends on 1)

A compound of formula (IB) according to claim 1 or a salt thereof wherein n in R1 is 0 or 1; and R1 is halo or NR7R8.

### Claim 6 (depends on 1)

A compound of formula (IA) according to claim 1 or a salt thereof which is:
N-[(3R)-1-cyano-3-pyrrolidinyl]-5-methyl-2-(methyloxy)benzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-2-methylbenzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-3,5-bis(trifluoromethyl)benzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-2,5-bis(methyloxy)benzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-2,5-bis(methyloxy)benzenesulfonamide;
3-cyano-N-[(3R)-1-cyano-3-pyrrolidinyl]benzenesulfonamide;
3-chloro-N-[(3R)-1-cyano-3-pyrrolidinyl]benzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-2,5-bis(trifluoromethyl)benzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-2-fluoro-5-methylbenzenesulfonamide;
5-chloro-N-[(3R)-1-cyano-3-pyrrolidinyl]-2-fluorobenzenesulfonamide;
3-bromo-N-[(3R)-1-cyano-3-pyrrolidinyl]benzenesulfonamide;
2-bromo-N-[(3R)-1-cyano-3-pyrrolidinyl]benzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-2,3,5,6-tetramethylbenzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)benzamide;
2-chloro-N-[(3R)-1-cyano-3-pyrrolidinyl]benzenesulfonamide;
3,5-dichloro-N-[(3R)-1-cyano-3-pyrrolidinyl]benzenesulfonamide;
3-chloro-N-[(3R)-1-cyano-3-pyrrolidinyl]-2-methylbenzenesulfonamide;
2,6-dichloro-N-[(3R)-1-cyano-3-pyrrolidinyl]benzenesulfonamide;
2-cyano-N-[(3R)-1-cyano-3-pyrrolidinyl]benzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-5-fluoro-2-methylbenzenesulfonamide;
2,5-dibromo-N-[(3R)-1-cyano-3-pyrrolidinyl]benzenesulfonamide;
2,5-dichloro-N-[(3R)-1-cyano-3-pyrrolidinyl]benzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-3-(trifluoromethyl)benzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-3-methylbenzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-2,5-dimethylbenzenesulfonamide;
2-chloro-N-[(3R)-1-cyano-3-pyrrolidinyl]-5-(trifluoromethyl)benzenesulfonamide;
2-bromo-N-[(3R)-1-cyano-3-pyrrolidinyl]-5-nitrobenzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-5-{[(ethylamino)carbonyl]amino}-2-(methyloxy)benzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-2-(methyloxy)-5-{[(phenylamino)carbonyl]amino}benzenesulfonamide;
5-amino-N-[(3R)-1-cyano-3-pyrrolidinyl]-2-(methyloxy)benzenesulfonamide;
2-bromo-N-[(3R)-1-cyano-3-pyrrolidinyl]-5-(trifluoromethyl)benzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-3-(5-methyl-1,3,4-oxadiazol-2-yl)benzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-2,6-difluorobenzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-2,5-difluorobenzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-3-fluorobenzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-4′-fluoro-3-biphenylsulfonamide;
5-bromo-N-[(3R)-1-cyano-3-pyrrolidinyl]-2-(methyloxy)benzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-3-(methyloxy)benzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-5-{[(3-hydroxyphenyl)methyl]amino}-2-(methyloxy)benzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-5-(ethylamino)-2-(methyloxy)benzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-5-[(2,3-dihydroxypropyl)amino]-2-(methyloxy)benzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-5-[(cyclopropylmethyl)amino]-2-(methyloxy)benzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-2-(methyloxy)-5-(pentylamino)benzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-5-[(3-methylbutyl)amino]-2-(methyloxy)benzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-5-[(2-methylbutyl)amino]-2-(methyloxy)benzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-5-[(3,3-dimethylbutyl)amino]-2-(methyloxy)benzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-5-[(3-furanylmethyl)amino]-2-(methyloxy)benzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-2-(methyloxy)-5-[(2-methylpentyl)amino]benzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-2-(methyloxy)-5-[(3-methylpentyl)amino]benzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-2-(methyloxy)-5-(nonylamino)benzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-2-(methyloxy)-5-[(1,3-thiazol-2-ylmethyl)amino]benzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-2-(methyloxy)-5-[(phenylmethyl)amino]benzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-5-{[(3-fluorophenyl)methyl]amino}-2-(methyloxy)benzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-5-{[(4-hydroxyphenyl)methyl]amino}-2-(methyloxy)benzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-5-(2-furanylamino)-2-methylbenzenesulfonamide;
5-[(2-chloroethyl)amino]-N-[(3R)-1-cyano-3-pyrrolidinyl]-2-methylbenzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-5-[(2,3-dihydroxypropyl)amino]-2-methylbenzenesulfonamide;
5-(butylamino)-N-[(3R)-1-cyano-3-pyrrolidinyl]-2-methylbenzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-2-methyl-5-(pentylamino)benzenesulfonamide;
5-[bis(3-methylbutyl)amino]-N-[(3R)-1-cyano-3-pyrrolidinyl]-2-methylbenzenesulfonamide;
5-[bis(3,3-dimethylbutyl)amino]-N-[(3R)-1-cyano-3-pyrrolidinyl]-2-methylbenzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-2-methyl-5-[(2-methylpentyl)amino]benzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-5-(dimethylamino)-2-methylbenzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-2-methyl-5-[(1,3-thiazol-2-ylmethyl)amino]benzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-2-methyl-5-[(phenylmethyl)amino]benzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-5-{[(3-fluorophenyl)methyl]amino}-2-methylbenzenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-5-{[(3-hydroxyphenyl)methyl]amino}-2-methylbenzenesulfonamide;
2-chloro-N-[(3R)-1-cyano-3-pyrrolidinyl]-5-(2-furanylamino)benzenesulfonamide;
2-chloro-5-[(2-chloroethyl)amino]-N-[(3R)-1-cyano-3-pyrrolidinyl]benzenesulfonamide;
2-chloro-5-[(2,3-dihydroxypropyl)amino]-N-[(3R)-1-ethynyl-3-pyrrolidinyl]benzenesulfonamide;
5-(butylamino)-2-chloro-N-[(3R)-1-ethynyl-3-pyrrolidinyl]benzenesulfonamide;
2-chloro-N-[(3R)-1-cyano-3-pyrrolidinyl]-5-(pentylamino)benzenesulfonamide;
2-chloro-N-[(3R)-1-cyano-3-pyrrolidinyl]-5-[(3-methylbutyl)amino]benzenesulfonamide;
2-chloro-N-[(3R)-1-cyano-3-pyrrolidinyl]-5-[(2-methylbutyl)amino]benzenesulfonamide;
1-{[4-chloro-3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)phenyl]amino}-1,2-dide;oxy-D-erythro-pentitol
2-chloro-N-[(3R)-1-cyano-3-pyrrolidinyl]-5-[(3,3-dimethylbutyl)amino]benzenesulfonamide;
2-chloro-N-[(3R)-1-cyano-3-pyrrolidinyl]-5-[(3-furanylmethyl)amino]benzenesulfonamide;
2-chloro-N-[(3R)-1-cyano-3-pyrrolidinyl]-5-[(2-methylpentyl)amino]benzenesulfonamide;
2-chloro-N-[(3R)-1-cyano-3-pyrrolidinyl]-5-(methylamino)benzenesulfonamide;
2-chloro-N-[(3R)-1-cyano-3-pyrrolidinyl]-5-[(1,3-thiazol-2-ylmethyl)amino]benzenesulfonamide;
2-chloro-N-[(3R)-1-cyano-3-pyrrolidinyl]-5-[(phenylmethyl)amino]benzenesulfonamide;
2-chloro-N-[(3R)-1-cyano-3-pyrrolidinyl]-5-{[(3-fluorophenyl)methyl]amino}benzenesulfonamide;
2-chloro-N-[(3R)-1-cyano-3-pyrrolidinyl]-5-{[(3-hydroxyphenyl)methyl]amino}benzenesulfonamide;
N-[3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)-4-(methyloxy)phenyl]-2-(methyloxy)benzamide;
N-[3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)-4-(methyloxy)phenyl]-2-[4-(methyloxy)phenyl]acetamide;
N-[3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)-4-(methyloxy)phenyl]-4-pentenamide;
N-[3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)-4-(methyloxy)phenyl]pentanamide;
N-[3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)-4-(methyloxy)phenyl]-3-methylbutanamide;
N-[3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)-4-(methyloxy)phenyl]-2,2-dimethylpropanamide;
N-[3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)-4-(methyloxy)phenyl]cyclopentanecarboxamide;
N-[3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)-4-(methyloxy)phenyl]tetrahydro-2H-pyran-4-carboxamide;
N-[3-({[(3R)-1-ethynyl-3-pyrrolidinyl]amino}sulfonyl)-4-(methyloxy)phenyl]-2-methylpentanamide;
N-[3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)-4-(methyloxy)phenyl]hexanamide;
N-[3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)-4-(methyloxy)phenyl]propanamide;
N-[3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)-4-(methyloxy)phenyl]-2-ethylbutanamide;
N-[3-({[(3R)-1-ethynyl-3-pyrrolidinyl]amino}sulfonyl)-4-(methyloxy)phenyl]-3-methylpentanamide;
N-[3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)-4-(methyloxy)phenyl]-5-methyl-2-(trifluoromethyl)-3-furancarboxamide;
N-[3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)-4-(methyloxy)phenyl]-5-methyl-2-(trifluoromethyl)-3-furancarboxamide;
N-[3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)-4-(methyloxy)phenyl]-2,2,3,3-tetrafluoropropanamide;
N-[3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)-4-(methyloxy)phenyl]-3-(methyloxy)propanamide;
N-[3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)-4-(methyloxy)phenyl]cyclobutanecarboxamide;
N-[3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)-4-(methyloxy)phenyl]-2-furancarboxamide;
5-chloro-N-[3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)-4-methylphenyl]-1-methyl-1H-pyrazole-4-carboxamide;
N-[3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)-4-methylphenyl]pentanamide;
N-[3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)-4-methylphenyl]-3-methylbutanamide;
N-[3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)-4-methylphenyl]-2-methylbutanamide;
N-[3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)-4-methylphenyl]-2,2-dimethylpropanamide;
N-[3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)-4-methylphenyl]cyclopentanecarboxamide;
N-[3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)-4-methylphenyl]tetrahydro-2H-pyran-4-carboxamide;
N-[3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)-4-methylphenyl]-2-methylpentanamide;
N-[3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)-4-methylphenyl]propanamide;
N-[3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)-4-methylphenyl]-2-ethylbutanamide;
N-[3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)-4-methylphenyl]-3-methylpentanamide;
N-[3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)-4-methylphenyl]-5-methyl-2-(trifluoromethyl)-3-furancarboxamide;
N-[3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)-4-methylphenyl]heptanamide;
N-[3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)-4-methylphenyl]-3-(methyloxy)propanamide;
N-[3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)-4-methylphenyl]cyclobutanecarboxamide;
N-[4-chloro-3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)phenyl]-3-(methyloxy)propanamide;
N-[4-chloro-3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)phenyl]-4-pentenamide;
N-[4-chloro-3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)phenyl]pentanamide;
N-[4-chloro-3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)phenyl]-3-methylbutanamide;
N-[4-chloro-3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)phenyl]-2,2-dimethylpropanamide;
N-[4-chloro-3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}-sulfonyl)phenyl]cyclopentanecarboxamide;
N-[4-chloro-3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)phenyl]tetrahydro-2H-pyran-4-carboxamide;
N-[4-chloro-3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)phenyl]-2-methylpentanamide;
N-[4-chloro-3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}-sulfonyl)phenyl]propanamide;
N-[4-chloro-3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)phenyl]-2-ethylbutanamide;
N-[4-chloro-3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)phenyl]-3-methylpentanamide;
5-chloro-N-[4-chloro-3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)phenyl]-1-methyl-1H-pyrazole-4-carboxamide;
N-[4-chloro-3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)phenyl]-5-methyl-2-(trifluoromethyl)-3-furancarboxamide;
N-[4-chloro-3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}-sulfonyl)phenyl]heptanamide;
N-[4-chloro-3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)phenyl]-2,2,3,3-tetrafluoropropanamide;
N-[4-chloro-3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)-phenyl]cyclobutanecarboxamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-2,5-bis[(2,2,2-trifluoroethyl)oxy]benzenesulfonamide; or
methyl 3-({[(3R)-1-cyano-3-pyrrolidinyl]amino}sulfonyl)-4-(methyloxy)benzoate.

### Claim 7 (depends on 1)

A compound of formula (IB) according to claim 1 or a salt thereof which is
5-chloro-N-[(3R)-1-cyano-3-pyrrolidinyl]-1-naphthalenesulfonamide;
N-[(3R)-1-cyano-3-pyrrolidinyl]-1-naphthalenesulfonamide; or
5-(dimethylamino)-N-[(3R)-1-ethynyl-3-pyrrolidinyl]-1-naphthalenesulfonamide.

### Claim 8 (depends on 1)

A pharmaceutical composition comprising a compound of formula (IA) or (IB) according to claim 1 or a pharmaceutically acceptable salt thereof and one or more of pharmaceutically acceptable carriers, diluents and excipients.

### Claim 9 (depends on 1)

A method for treating COPD comprising administering an effective amount of a compound of formula (IA) or (IB) according to claim 1 or a pharmaceutically acceptable salt thereof neat or admixed with a pharmaceutically acceptable carrier.
